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Abstract
Perfluorocarbons accumulate in the dependent regions of the lungs, which may result in
regional hypoxia if ventilation with oxygen is insufficient to oxygenate the dependent
perfluorocarbon-filled alveoli. In this issue of Critical Care, Max et al present data that
demonstrate a decrease in arterial oxygen tension (PaO2) at 30 min compared to that
observed at 5 min after administration of FC 3280. These data suggest failure of on-going
ventilation/oxygenation to support the initial increase in PaO2 attributed to the oxygen
dissolved in the administered perfluorocarbon. Studies such as this one demonstrate that
development of the optimal partial liquid ventilation (PLV) technique is ongoing.
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PaO2 = arterial oxygen tension; PLV = partial liquid ventilation.
http://ccforum.com/content/4/2/067
PLV has piqued the fascination of critical care practitioners
since it was described in 1991 [1]. It was proposed to
enhance gas exchange in the setting of the acute respira-
tory distress syndrome, and laboratory studies quickly
demonstrated that alveolar recruitment and redistribution of
pulmonary blood flow, presumably due to the presence of
the high-density perfluorocarbons in the dependent regions
of the lungs, contributed to the observed improvement in
gas exchange [2–4]. It was also noted, both in the labora-
tory and the clinical settings, that perfluorocarbons accu-
mulated predominately in the dependent regions of the
lungs [5,6]. This observation led to the concern that areas
of relative hypoxia might exist if ventilation with oxygen was
insufficient to oxygenate the perfluorocarbon-filled alveoli in
these regions. It is worthwhile to note that oxygenation of
the perfluorocarbon-filled alveolus is likely dependent on
convection, rather than diffusion, because the diffusion of
oxygen in a liquid is several orders of magnitude less than
that in a gas. Whether this dependent hypoxic phenome-
non occurs has not been defined. Tutuncu et al [7] demon-
strated a reduction in oxygenation in normal rabbits in
which pulmonary perfluorocarbon was administered. That
ventilation–perfusion matching may be compromised in
these normal animals suggests that oxygenation of the
liquid-filled alveolus may be incomplete.
In this issue of Critical Care, Max et al [8] examine the
time course of changes in arterial oxygenation after admin-
istration of 7.5 ml/kg of the perfluorocarbon FC 3280 into
the lungs of saline lavage lung-injured pigs. Specifically,
the authors measured PaO2 and other physiologic para-
meters at 5 and 30 min after perfluorocarbon instillation,
with the hypothesis that a time-dependent decrease in
PaO2 would suggest failure of ongoing ventilation–oxy-
genation to support the initial increase in PaO2 attributed
to the oxygen dissolved in the administered perfluorocar-
bon. Indeed, the authors observed two important findings:
first, a dose-dependent increase in PaO2 was observed;Critical Care    Vol 4 No 2 Hirschl
and second, PaO2 at 30 min was significantly less than
that observed at 5 min after administration of 22.5 and
30 ml/kg FC 3280. The latter is an intriguing observation
that suggests that oxygenation of the perfluorocarbon may
be insufficient after initial administration. There are,
however, a number of issues that need to be considered
in the interpretation of these findings. One premise of the
derived conclusions is that the administered perfluorocar-
bon was sufficiently oxygenated so as to have a substan-
tial impact on PaO2. We have no information on the
oxygenation status of the perfluorocarbon at the time of
administration, however. Even so, the theoretic amount of
oxygen contributed by fully saturated FC 3280 would be
fairly small (approximately 3 ml O2/kg).
One enhancement to the study by Max et al [8] might be
to assess the effect of hyperoxygenated, room air, and
deoxygenated perfluorocarbon on pulmonary gas trans-
port at 5 min and 30 min after dosing. These data would
provide more convincing evidence that an increase in oxy-
genation at 5 min and the subsequent decrease at 30 min
were due to changes in perfluorocarbon oxygen content.
Other confounding variables that may affect the difference
in PaO2 between 5 and 30 min include evaporation of FC
3280 and changes in other physiologic variables, such as
cardiac output, which might independently affect PaO2.
For instance, oxygen delivery, probably the most important
parameter of oxygen dynamics, is not significantly different
between the 5-min and 30-min time periods in the study.
Studies such as that by Max et al [8] contribute toward
refining the PLV technique; these data might suggest that
application of higher levels of peak inspiratory pressure or
positive end-expiratory pressure could enhance gas distri-
bution and minimize the effects observed. The technique
of perfluorocarbon administration and the amount dosed
may need to be altered. It would be intriguing to consider
whether similar findings would be observed in newborn
animals in which the relatively small height of the chest is
less likely to provide regional differences in perfluorocar-
bon and gas distribution.
A randomized, controlled, multicentered study evaluating
PLV in adults with the acute respiratory distress syndrome
is underway. However, the pilot study preceding that trial
[9] failed to demonstrate an enhancement in parameters
of oxygenation in the PLV group when compared with the
conventional mechanical ventilation group. We have much
to learn about PLV and, even though it is currently under-
going clinical trials, we are still defining the optimal appli-
cation of this technique.
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